NCT02957422 is a NA clinical trial of 1% Milk in Brain Aging, sponsored by University of Kansas Medical Center.

Who is sponsoring NCT02957422?

NCT02957422 is sponsored by University of Kansas Medical Center.

What drugs are being tested in NCT02957422?

Interventions in NCT02957422: 1% Milk, Control.

What condition does NCT02957422 study?

NCT02957422 studies Brain Aging.

Is NCT02957422 still recruiting?

NCT02957422 is currently completed. Last updated 19 May 2021.

Last reviewed 2021-05-19 · How we verify

NCT02957422

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Milk Intervention Study for Brain Aging

Completed NA Last updated 19 May 2021

What this trial tests

NA trial testing 1% Milk in Brain Aging in 70 participants. Completed in 11 September 2019.

Timeline

7 April 2017

Primary endpoint
11 September 2019

11 September 2019

Quick facts

Lead sponsor	University of Kansas Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	70
Start date	7 April 2017
Primary completion	11 September 2019
Estimated completion	11 September 2019
Sites	1 location across United States

Drugs / interventions tested

1% Milk
Control

Conditions studied

Brain Aging — all drugs for Brain Aging →

Sponsor

University of Kansas Medical Center

Who can join

Adults 60 to 89, any sex, with Brain Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to learn if increased dairy food consumption helps brain health in older adults by protecting nerve cells from damage.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Milk intake enhances cerebral antioxidant (glutathione) concentration in older adults: A randomized controlled intervention study.
Choi IY, Taylor MK, Lee P, Alhayek SA, et al · · 2022 · cited 4× · PMID 36046132 · DOI 10.3389/fnut.2022.811650

Verify or expand the search:

Other recruiting trials for Brain Aging

Currently open trials in the same condition.

NCT07209683 — The Effect of Near-infrared Light Therapy on Brain Function and Cognition in Young and Older Adults · NA · recruiting

Other University of Kansas Medical Center trials

Trials by the same sponsor.

NCT06636214 — Adapting Changing Talk: Online (CHATO) to CHATO-Inclusive · NA · not yet recruiting
NCT07528963 — KanSurvive 2.0: Testing Enhanced Models of Cancer Survivorship Care for Rural Cancer Survivors in Primary Care Practice · NA · enrolling by invitation
NCT07463755 — Low-Fidelity Driving Simulator Training in Parkinson's Disease. · NA · not yet recruiting
NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07491510 — Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02957422 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Kansas Medical Center
Last refreshed: 19 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02957422.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing